Mounjaro fda approval date?

When did the FDA approve Mounjaro (tirzepatide)?

The FDA approved Mounjaro (tirzepatide) on May 13, 2022 for adults with type 2 diabetes as an injection. [1]

What was Mounjaro’s first approval for?

That initial FDA approval was for improving glycemic control in adults with type 2 diabetes. [1]

Has the FDA approved Mounjaro for other uses since then?

Mounjaro has also received additional FDA approvals for broader clinical use beyond the original label, with later updates reflected in subsequent FDA actions. [1]

Sources:
[1] https://www.drugs.com/history/mounjaro.html